Skip to main content
Clinical Trials/NCT07459699
NCT07459699
Not yet recruiting
Not Applicable

Randomised, Placebo-controlled Pilot Study to Assess the Effects of Probiotics on the Gut-brain Axis in Children With Attention Deficit Hyperactivity Disorder

Probi AB1 site in 1 country80 target enrollmentStarted: March 1, 2026Last updated:
InterventionsPlaceboProbiotics

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Probi AB
Enrollment
80
Locations
1
Primary Endpoint
Conner's Continuous Performance test-3 (CPT-3) hit reaction time (HRT) block change score

Overview

Brief Summary

The effect of probiotics on the gut-brain axis in children with attention deficit hyperactivity disorder will be studied.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
8 Years to 11 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Males and females aged 8 - 11 years
  • With mild ADHD symptoms
  • Patient and parents (legal representatives) able and willing to participate in the research by complying with the protocol procedures

Exclusion Criteria

  • Metabolic disorder
  • Severe chronic disease
  • GI disorders found to be inconsistent with the conduct of the study by the investigator
  • Neurological disorder involving central function (e.g., intellectual disability, autism spectrum disorder, epilepsy, narcolepsy)
  • Currently treated with a medication with primary central nervous system activity or major psychiatric condition requiring hospitalization
  • With a known or suspected food allergy or intolerance or hypersensitivity to any of the study products' ingredients
  • Having taken prebiotic or probiotic treatment in the month prior to inclusion, or having taken antibiotics for more than one week in the 3 months prior to inclusion,
  • Taking part in another clinical trial or being in the exclusion period of a previous clinical trial,
  • Parents (legal representatives) presenting a psychological or linguistic incapability to sign the ICF,
  • Parents (legal representatives) impossible to contact in case of emergency.

Arms & Interventions

Placebo

Placebo Comparator

Intervention: Placebo (Dietary Supplement)

Probiotics

Active Comparator

Intervention: Probiotics (Dietary Supplement)

Outcomes

Primary Outcomes

Conner's Continuous Performance test-3 (CPT-3) hit reaction time (HRT) block change score

Time Frame: 12 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Probi AB
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials